Journal of Personalized Medicine (Apr 2022)

Efficacy of Telemedicine and At-Home Telemonitoring following Hospital Discharge in Patients with COVID-19

  • Roi Suárez-Gil,
  • Emilio Casariego-Vales,
  • Rosa Blanco-López,
  • Fernando Santos-Guerra,
  • Cristina Pedrosa-Fraga,
  • Álvaro Fernández-Rial,
  • Iria Íñiguez-Vázquez,
  • María Mar Abad-García,
  • Mercedes Bal-Alvaredo,
  • on behalf of the members of the Lugo TELEA-COVID Team

DOI
https://doi.org/10.3390/jpm12040609
Journal volume & issue
Vol. 12, no. 4
p. 609

Abstract

Read online

Aim: This work aims to evaluate the safety and utility of an at-home telemedicine with telemonitoring program for discharged COVID-19 patients. Methods: This is a retrospective cohort study of all patients discharged home in Galicia between 6 March 2020 and 15 February 2021. We evaluated a structured, proactive monitoring program conducted by the ASLAM (Área Sanitaria de Lugo, A Mariña y Monforte de Lemos) Healthcare Area team compared to patients discharged in the rest of the Autonomous Community of Galicia. Results: During the study period, 10,517 patients were hospitalized for COVID-19 and 8601 (81.8%) were discharged. Of them, 738 (8.6%) were discharged in ASLAM and 7863 (91.4%) were discharged in the rest of Galicia. Of those discharged in ASLAM, 475 (64.4%) patients were monitored. Compared to patients in the rest of Galicia, the group monitored via telemedicine had a significantly shorter first hospital stay (p p = 0.05), and a shorter second hospital stay (p = 0.04), with no differences in emergency department visits or 90-day all-cause mortality. Conclusion: A structured, proactive telemedicine with telemonitoring program for discharged COVID-19 patients is a safe, useful tool that reduces the mean length of hospital stay and readmissions.

Keywords